ublituximab,teriflunomide
sanofi,tg therapeutics
['ublituximab', 'multiple sclerosis', 'briumvi', 'ultimate i,(-ultimate ii)', 'tg therapeutics', '$tgtx']
tg therapeutics announces presentation of data from the ultimate i &amp; ii phase 3 trials of briumvi (ublituximab-xiiy) in multiple sclerosis at the #aanam $tgtx 
No investment advice. Do your own DD Market is all about taking the shares from the weak holders& providing opportunities to those that have the stamina to hold